Sand Hill Global Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Sell
762
-63
-8% -$22.5K 0.01% 175
2025
Q4
$270K Buy
+825
New +$262K 0.01% 176
2025
Q3
Sell
-720
Closed -$201K 200
2025
Q2
$201K Buy
720
+21
+3% +$5.95K 0.01% 197
2025
Q1
$218K Buy
+699
New +$206K 0.01% 182
2024
Q4
Sell
-707
Closed -$228K 190
2024
Q3
$228K Buy
707
+54
+8% +$17.7K 0.01% 181
2024
Q2
$204K Buy
+653
New +$192K 0.01% 185
2020
Q1
Sell
-910
Closed -$219K 119
2019
Q4
$219K Buy
+910
New +$201K 0.02% 130
2019
Q2
Sell
-1,230
Closed -$234K 104
2019
Q1
$234K Buy
1,230
+130
+12% +$24.8K 0.02% 99
2018
Q4
$214K Hold
1,100
0.02% 100
2018
Q3
$228K Sell
1,100
-185
-14% -$36.5K 0.02% 98
2018
Q2
$237K Buy
+1,285
New +$227K 0.02% 96
2017
Q4
Sell
-1,100
Closed -$205K 111
2017
Q3
$205K Buy
+1,100
New +$195K 0.02% 109

Other funds holding AMGN

Sand Hill Global Advisors's AMGN Position: Q1 2026 in Review

Sand Hill Global Advisors reduced its Amgen (AMGN) stake by 7.6% in Q1 2026, selling an estimated $22.5K and leaving 762 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #175.

Sand Hill Global Advisors first reported a position in AMGN in Q3 2017 and has held it in 12 quarters since. The position peaked at $270K in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Sand Hill Global Advisors held 762 shares of Amgen worth $268K as of Q1 2026.
  • Sand Hill Global Advisors sold 63 Amgen shares in Q1 2026, an estimated $22.5K.
  • Amgen made up 0.01% of Sand Hill Global Advisors's portfolio in Q1 2026, its #175 holding.
  • Sand Hill Global Advisors first reported a position in Amgen in Q3 2017 and has held it in 12 quarters since.
  • Sand Hill Global Advisors's Amgen position peaked at $270K in Q4 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Sand Hill Global Advisors's 13F filing for Q1 2026, filed 14 May 2026.